1 study found for:    20460632 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Kidney Cancer;   Liver Cancer;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: talabostat mesylate;   Drug: temozolomide;   Other: pharmacological study

Indicates status has not been verified in more than two years